Researchers examine readmissions to hospital after delivery in women with psychiatric disorders

According to the Centers for Disease Control and Prevention (CDC), gestational diabetes affects about 2 to 10% of pregnancies in the United States. In the absence of treatment, gestational diabetes can cause complications during pregnancy, including prematurity, caesarean section, etc.

The American College of Obstetricians and Gynecologists (ACOG) recommends that all pregnant women be screened for gestational diabetes. According to the ACOG, routine screening for gestational diabetes should occur between 24 and 28 weeks of gestation, with earlier screening (at the first prenatal visit) for women with certain risk factors, including pregnancy. ;obesity. To date, however, there have been no randomized controlled trials (RCTs) demonstrating that early detection in obese women gives better results at birth.

In a study to be presented on February 14, 2019 at the annual meeting of the Society for Maternal-Fetal Medicine (SMFM), The Pregnancy Meeting, researchers will unveil findings suggesting that early detection of gestational diabetes in obese women not lead to better birth results compared to screening performed at the routine period. The research was funded by the National Institute of Child Health and Human Development Eunice Kennedy Shiver.

In the study, 959 obese pregnant women were randomized into two groups. The first group was examined between 14 and 20 weeks. The second group was examined at 24-28 weeks. Various birth outcomes have been examined, including caesarean birth rate, shoulder dystocia, hypertension, macrosomia, neonatal hypoglycemia, and miscarriage. 39, neonatal hyperbilirubinemia, etc.

"The only notable difference between the women in the early screening group and those in the routine screening group was an increase in the use of insulin in the early detection group," said Lorie M. Harper. MD, MSCI, senior author of the abstract and badociate professor at the University of Alabama in Birmingham. Although the use of insulin during pregnancy does not present significant danger, its injection can be painful and expensive.

"The results of our study suggest that early detection in obese women is not beneficial," Harper said. "As this was the first of its kind, additional studies are needed to evaluate early detection in a large and diverse population, as well as the best screening thresholds to use early in pregnancy. "

Provided by
Society of Maternal and Fetal Medicine